Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics , today announced the Company will be participating in two upcoming investor conferences. Corindus Vascular Robotics' management is scheduled to present at the Stifel 2016 Healthcare Conference in New York, NY on Wednesday, November 16 at 9:30am ET. Corindus Vascular Robotics' management is also scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY on Thursday, November 17 at 3:40pm ET. Interested parties may access the audio webcast for both presentations on the "Investor Relations" section of the Company's website at: www.corindus.com. About Corindus Vascular Robotics, Inc. Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company's CorPath ® System is the first FDA-cleared medical device to bring robotic-assisted precision to interventional procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program." For additional information, visit www.corindus.com, and follow @CorindusInc.